Guidelines on the Prevention and Control of Tuberculosis in Ireland
Guidelines on the Prevention and Control of Tuberculosis in Ireland
Guidelines on the Prevention and Control of Tuberculosis in Ireland
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<str<strong>on</strong>g>Guidel<strong>in</strong>es</str<strong>on</strong>g> <strong>on</strong> <strong>the</strong> Preventi<strong>on</strong> <strong>and</strong> C<strong>on</strong>trol <strong>of</strong> <strong>Tuberculosis</strong> <strong>in</strong> Irel<strong>and</strong> 2010HSE/HPSCRisk assessment for all c<strong>on</strong>firmed or suspected pulm<strong>on</strong>ary or laryngeal TB cases. 26Recommendati<strong>on</strong>:All patients with suspected or known pulm<strong>on</strong>ary or laryngeal TB must have a risk assessmentfor MDR-TB.Risk factors for MDR-TB <strong>in</strong>clude <strong>the</strong> follow<strong>in</strong>g:• A history <strong>of</strong> prior TB treatment (especially <strong>in</strong>complete treatment) <strong>and</strong>/or prior TB treatmentfailure• C<strong>on</strong>tact with a known case <strong>of</strong> MDR-TB• Birth <strong>in</strong> a foreign country, particular a high <strong>in</strong>cidence country for MDR-TB (Lithuania, Est<strong>on</strong>ia,Latvia, Uzbekistan, Kazakhstan, Ch<strong>in</strong>a ( Henan & Lia<strong>on</strong><strong>in</strong>g prov<strong>in</strong>ces) Tomsk Oblast (RussianFederati<strong>on</strong>) <strong>and</strong> Ecuador) (refer to www.who.<strong>in</strong>t/tb/publicati<strong>on</strong>s/mdr_surveillance/en/<strong>in</strong>dex.htmlfor latest <strong>in</strong>formati<strong>on</strong> <strong>on</strong> countries with high <strong>in</strong>cidence <strong>of</strong> MDR-TB)• HIV <strong>in</strong>fecti<strong>on</strong>Recommendati<strong>on</strong>:Patients with suspected or c<strong>on</strong>firmed MDR-TB must be admitted to an airborne isolati<strong>on</strong> room(negative pressure isolati<strong>on</strong> room with an ante room or a neutral pressure design as outl<strong>in</strong>ed <strong>in</strong>HBN 04 supplement 1). (This may require transferr<strong>in</strong>g <strong>the</strong> patient to ano<strong>the</strong>r <strong>in</strong>stituti<strong>on</strong> where<strong>the</strong> facilities, toge<strong>the</strong>r with a physician experienced <strong>in</strong> <strong>the</strong> management <strong>of</strong> complex drugresistantcases are available).See figure 6.1 for risk assessment for patient placement if a sufficient number <strong>of</strong> airborne isolati<strong>on</strong> roomsare not available.-78-